Informační systém MU
FOLTA, Adam, Markéta SASINKOVA, Anna ĎURINÍKOVÁ, Marie DRNCOVÁ, Barbora WEINBERGEROVÁ, Jiří MAYER and Ivana JEŽÍŠKOVÁ. Effective NPM1 plasmid standards selection for minimal/measurable residual disease monitoring in acute myeloid leukemia. Molecular Biology Reports. DORDRECHT: SPRINGER, 2022, vol. 49, No 8, p. 8169-8172. ISSN 0301-4851. Available from: https://dx.doi.org/10.1007/s11033-022-07363-8.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Effective NPM1 plasmid standards selection for minimal/measurable residual disease monitoring in acute myeloid leukemia.
Authors FOLTA, Adam (203 Czech Republic), Markéta SASINKOVA (203 Czech Republic), Anna ĎURINÍKOVÁ (703 Slovakia, belonging to the institution), Marie DRNCOVÁ (203 Czech Republic, belonging to the institution), Barbora WEINBERGEROVÁ (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Ivana JEŽÍŠKOVÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Molecular Biology Reports, DORDRECHT, SPRINGER, 2022, 0301-4851.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.800
RIV identification code RIV/00216224:14110/22:00126108
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s11033-022-07363-8
UT WoS 000812606600010
Keywords in English Nucleophosmine 1; Acute myeloid leukemia; Quantitative PCR standards; Colony selection; Cloning
Tags 14110212, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 8/12/2022 12:37.
Abstract
Background NPM1 plasmid standards are required for absolute quantification of minimal residual disease in acute myeloid leukemia patients. The standards are usually obtained, next to commercially constructed gene fragments, from transgenic bacteria colonies. However, this procedure is laborious and very time consuming. Methods and results We have developed a PCR method that speeds up, simplifies, and streamlines the process of preparing NPM1 plasmid standards. The method is based on a combination of three primers, two surrounding the usual NPM1 mutation position and one over the mutation site. With this method, we were able to clearly distinguish plasmids with at least 15 different NPM1 mutations from the wild-type NPM1 plasmid. Conclusions With the new approach, preparing NPM1 plasmid standards is easier, identifying NPM1-positive colonies is possible in less than a day and moreover, for a lower price than commercially constructed gene fragments.
Links
MUNI/A/1330/2021, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IX (Acronym: VýDiTeHeMa IX)
Investor: Masaryk University
Displayed: 16/7/2024 10:42